Back to SO Squarepoint Ops LLC

KNSAKNSA
9 quarters

Position history for SOSquarepoint Ops LLC's holdings in Kiniksa Pharmaceuticals International, plc

Yes. Squarepoint Ops holds 140,059 shares of KNSA (Kiniksa Pharmaceuticals International), worth $9M, as of its Q2 2026 13F filing. It reduced the position by 18,034 shares (-11.4%) from Q1 2026. Squarepoint Ops has held KNSA since Q4 2024, across 7 quarterly 13F filings.

Current Value

$9M

Current Shares

140,059

Total Value Change

+$8.5M

Total Shares Change

+115,214

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
140,059
-11.4%
$9M0.0%$63.95
0
2026-Q1
Increased
158,093
+85.6%
$7.6M0.0%$48.15
43
2025-Q4
Decreased
85,182
-0.0%
$3.5M0.0%$41.25
0
2025-Q3
Decreased
85,198
-79.5%
$3.3M0.0%$38.83
0
2025-Q2
Increased
416,572
+186.2%
$11.5M0.0%$27.67
45
2025-Q1
Increased
145,567
+443.0%
$3.2M0.0%$22.21
43
2024-Q4
New
26,808
-
$530,2620.0%$19.78
34
2024-Q3
Exited
0
-100.0%
$00.0%$24.99
0
2024-Q2
New
24,845
-
$463,8560.0%$18.67
33

Other major holders of KNSA: FMR LLC, Baker Bros. Advisors LP, BlackRock, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used